Startseite>>Lipids>> Fatty Acids>>cis-Vaccenic Acid-d13

cis-Vaccenic Acid-d13 (Synonyms: 18:1 cis-11-d13, cis-11-Octadecenoic Acid-d13)

Katalog-Nr.GC47095

cis-VaccensÄure-d13 ist die mit Deuterium markierte cis-VaccensÄure. cis-VaccensÄure, der antivirale Extrakt aus der Rhodopseudomonas-Kapsel und der vorherrschende aktive Bestandteil der Rhodopseudomonas-Kapsel, wirkt als potenzieller Induktor fÖtaler HÄmoglobine.

Products are for research use only. Not for human use. We do not sell to patients.

cis-Vaccenic Acid-d13 Chemische Struktur

Cas No.: N/A

Größe Preis Lagerbestand Menge
1 mg
60,00 $
Auf Lager
5 mg
271,00 $
Auf Lager
10 mg
511,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

cis-Vaccenic acid-d13 is intended for use as an internal standard for the quantification of cis-vaccenic acid by GC- or LC-MS. cis-Vaccenic acid is an ω-7 fatty acid that has been found in mango pulp.1 It induces differentiation of, and γ-globin synthesis in, K562 and JK-1 cells, as well as isolated sickle cell transgenic mouse bone marrow erythroid progenitor cells (TMbmEPSCs).2

1.Shibahara, A., Yamamoto, K., Nakayama, T., et al.cis-Vaccenic acid in mango pulp lipidsLipids21(6)388-394(1986) 2.Aimola, I.A., Inuwa, H.M., Nok, A.J., et al.Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cellsEur. J. Pharmacol.7769-18(2016)

Bewertungen

Review for cis-Vaccenic Acid-d13

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for cis-Vaccenic Acid-d13

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.